Identifying Individuals at High Risk for Alzheimers Disease Among Hispanics Using Single and Multi-Ancestry Polygenic Risk Scores
Yuexuan Xu,Min Qiao,TAMIL INIYAN GUNASEKARAN,Yian Gu,Dolly Reyes-Dumeyer,Angel Piriz,Danurys L Sanchez,Belisa Soriano,Yahaira Franco,Zoraida Dominguez Coronado,Patricia Recio,Diones Rivera Mejia,Martin Medrano,Rafael A Lantigua,Lawrence S Honig,Jennifer J Manly,Adam M Brickman,Badri N Vardarajan,Richard Mayeux
DOI: https://doi.org/10.1101/2024.10.21.24315877
2024-10-22
Abstract:Introduction: Polygenic risk score (PRS) is effective in predicting AD risk among Europeans but remains understudied in Hispanics. Diverse genome-wide association studies (GWAS) data across multiple ancestries may improve PRS predictions. We evaluated PRS performance to predict AD disease risk using novel methods in the largest available African, European, and Hispanic GWAS for AD.
Methods: Prediction performance of APOE, single-ancestry PRS, and multi-ancestry PRS derived from GWAS-focused and method-focused approaches to clinical AD, incident AD, and cognition were evaluated in 2,961 Hispanics from two large studies. The GWAS-focused approach constructs PRS based on multi-ancestry GWAS, while the method-focused approach uses novel multi-ancestry PRS methods, integrating GWAS summary statistics across ancestries. Ten repetitions of 5-fold cross-validation were used. In a subset, plasma biomarker data were used in a tuning-validation split to examine PRS performance in predicting single and combined biomarkers.
Findings: The multi-ancestry PRS excluding APOE, constructed using the method-focused approach, outperformed both single-ancestry and multi-ancestry PRSs from the GWAS-focused approach. The best method-focused PRS, incorporating summary statistics from GWASs of African, European, and Hispanic populations, explained up to 1.6%, 3.9%, and 1.7% of the variance in clinical AD, incident AD, and cognition, respectively - comparable to or even higher than the variance explained by the APOE. Similar findings were observed in biomarker analyses. APOE accounted for more variation in plasma P-tau levels and PRS explained more variation in amyloid levels.
Interpretation: Integrating novel multi-ancestry PRS methods with GWAS across ancestries enhances prediction accuracy for AD risk among Hispanics. APOE and PRS may point to different biological aspects of AD.
Funding: National Institutes of Health R01 AG072474, RF1 AG066107, 5R37AG015473, RF1AG015473, R56AG051876, R01 AG067501, and UL1TR001873.